Your browser doesn't support javascript.
loading
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner, L; Kontoyiannis, D; Raffalli, J; Mullane, K M; Vazquez, J; Anaissie, E J; Lipton, J; Jacobs, P; van Rensburg, J H Jansen; Rex, J H; Lau, W; Facklam, D; Buell, D N.
Affiliation
  • Ostrosky-Zeichner L; Division of Infectious Diseases, University of Texas Medical School-Houston, 6431 Fannin MSB 2.112, Houston, TX 77030, USA. Luis.Ostrosky-Zeichner@uth.tmc.edu
Eur J Clin Microbiol Infect Dis ; 24(10): 654-61, 2005 Oct.
Article in En | MEDLINE | ID: mdl-16261306
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Candidiasis / Fungemia / Lipoproteins / Antifungal Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Language: En Journal: Eur J Clin Microbiol Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2005 Document type: Article Affiliation country: United States
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides, Cyclic / Candidiasis / Fungemia / Lipoproteins / Antifungal Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Language: En Journal: Eur J Clin Microbiol Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS / MICROBIOLOGIA Year: 2005 Document type: Article Affiliation country: United States